Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastric Cancer Stage II”

890 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 890 results

Testing effectiveness (Phase 2)UnknownNCT04631757
What this trial is testing

Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 33
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT00447967
What this trial is testing

Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients

Who this might be right for
Gastric Cancer
Hellenic Oncology Research Group 110
Testing effectiveness (Phase 2)Study completedNCT02564367
What this trial is testing

Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction

Who this might be right for
Adenocarcinoma,StomachAdenocarcinoma, Esophagogastric Junction
AIO-Studien-gGmbH 30
Testing effectiveness (Phase 2)UnknownNCT05528367
What this trial is testing

Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Locally Advanced Gastric Cancer
Zhejiang Cancer Hospital 33
Testing effectiveness (Phase 2)Study completedNCT00454636
What this trial is testing

Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 158
Testing effectiveness (Phase 2)Active Not RecruitingNCT05185947
What this trial is testing

Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer

Who this might be right for
Gynecologic CancerGynecologic NeoplasmsPeritoneal Carcinomatosis+7 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00259987
What this trial is testing

Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus

Who this might be right for
Adenocarcinoma
GlaxoSmithKline 24
Testing effectiveness (Phase 2)WithdrawnNCT03766607
What this trial is testing

Trastuzumab Beyond Progression in HER2 Positive Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Korean South West Oncology Group
Testing effectiveness (Phase 2)UnknownNCT01641783
What this trial is testing

Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients

Who this might be right for
Gastric Adenocarcinoma
Yanqiao Zhang 40
Testing effectiveness (Phase 2)Study completedNCT01084330
What this trial is testing

Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer

Who this might be right for
Advanced Gastric CancerGastro-esophageal Junction Cancer
Novartis Pharmaceuticals 68
Large-scale testing (Phase 3)Looking for participantsNCT06232434
What this trial is testing

An Open Prospective Randomized Clinical Study of the Effectiveness, Tolerability and Safety of a Single Intraperitoneal Use of the Drug "Prospidelong, Powder for the Preparation of a Gel for Topical Use, 1000 mg in Vials, Package No. 1" in Patients With Disseminated Gastric Cancer, Phase I-II

Who this might be right for
Gastric Cancer With Peritoneal Dissemination
Research Institute for Physical Chemical Problems of the Belarusian State University 120
Not applicableActive Not RecruitingNCT06521528
What this trial is testing

A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test

Who this might be right for
Gastric Cancer
Novomics. Co., Ltd. 237
Testing effectiveness (Phase 2)Study completedNCT01525771
What this trial is testing

Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer

Who this might be right for
Stage IV Gastric Cancer With Metastasis
Asan Medical Center 37
Testing effectiveness (Phase 2)UnknownNCT03564834
What this trial is testing

Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients

Who this might be right for
Advanced Gastric Cancer
Peking University 180
Testing effectiveness (Phase 2)UnknownNCT04999332
What this trial is testing

Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerGastric AdenocarcinomaEffects of Chemotherapy+1 more
National Cheng-Kung University Hospital 58
Testing effectiveness (Phase 2)UnknownNCT00343668
What this trial is testing

S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Korean Cancer Study Group 44
Testing effectiveness (Phase 2)UnknownNCT05218148
What this trial is testing

SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma

Who this might be right for
HER2-positiveLocally Advanced Solid TumorImmunotherapy+4 more
Aiping Zhou 44
Testing effectiveness (Phase 2)Study completedNCT05400915
What this trial is testing

Two-Part, Phase Ib/II, Open Label, Single-Arm, Multi-center Study to Evaluate the Safety and Efficacy of Varlitinib in Combination With Weekly Paclitaxel in EGFR/HER2 Co-expressing Advanced or Metastatic Gastric Cancer Patients

Who this might be right for
Gastric Cancer
Yonsei University 27
Testing effectiveness (Phase 2)Study completedNCT00278863
What this trial is testing

Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial

Who this might be right for
Gastric Cancer
Asan Medical Center 96
Load More Results